Team:ITESM-Guadalajara/Property

From 2014.igem.org

(Difference between revisions)

Latest revision as of 18:56, 10 January 2015

INTELLECTUAL PROPERTY

Given the high-end technology and innovation Biophrame is creating, IP protection is needed.

Patent protection and trade secrets

The technology that we developed consists in:

The design of a genetically modified E. coli, that in our process is the responsible of the chitin deacetylation process.

We are currently patenting our first invention: the design of the genetically modified E. coli able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of Biophrame Technologies as moral person (once it is legally established).

On the other hand, we will keep our innovative chitosan purification process as a trade secret, but we plan to establish a patent for this invention in other step of our Company development.

Biophrame Technologies is a biotech company and manufacturer specialized in the production of Chitosan.

@@ Line 221: / Line 221: @@
 .faceBot{
-    background: black;
+    background: #202020;
 }
@@ Line 249: / Line 249: @@
    border-bottom: 1px solid #AAA;
    margin-bottom: 30px;
+}
+li.menu-item{
+  background: transparent !important;
 }
@@ Line 314: / Line 318: @@
    padding-left: 50px;
 }
+.invertir:hover {
+  -webkit-filter: invert(100%);
+}
 </style>
@@ Line 329: / Line 335: @@
     <div class="row">
    <div class="col-md-2"></div>
-  <div class="col-md-3"<a><img class="inicioLogo" src="https://static.igem.org/mediawiki/2014/5/55/BioPhrameIgem_logo.png" height="100"  width="auto" ></a></div>
+   <div class="col-md-3"><a href="https://2014.igem.org/Team:ITESM-Guadalajara"><img class="inicioLogo" src="https://static.igem.org/mediawiki/2014/5/55/BioPhrameIgem_logo.png" height="100"  width="auto" ></a></div>
    <div class="col-md-1"></div>
     <div class="col-md-6" >
@@ Line 360: / Line 366: @@
            <a href="https://2014.igem.org/Main_Page">
              <span>iGEM 2014</span>
+            <span class="green-effect"></span>
+          </a>
+</li><li class="menu-item">
+          <a href="https://2014.igem.org/Team:ITESM-Guadalajara/Notebook">
+            <span>Notebook</span>
              <span class="green-effect"></span>
            </a>
@@ Line 372: / Line 383: @@
 <div class="main-content">
    <div class="col-md-2 col-md-offset-2 left_menu">
-     <ul class="nav nav-pills nav-stacked">
+     <ul class="nav nav-pills nav-stacked text-right">
        <li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Company">The Company</a></li>
        <li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Product">Our Product</a></li>
@@ Line 389: / Line 400: @@
 <h2>INTELLECTUAL PROPERTY</h2>
-</br><p>
+</br><p align="justify">
 Given the high-end technology and innovation Biophrame is creating, IP protection is needed.
 </p>
 <hr/>
 <h4>Patent protection and trade secrets</h4>
-<p>The technology that we developed consists in:
+<p align="justify">The technology that we developed consists in:
-</p><p>
+</p><p align="justify">
-<ul><li>The design of a genetically modified E. coli, that in our process is the responsible of the chitin deacetylation process.
+<ul><li>The design of a genetically modified <i>E. coli</i>, that in our process is the responsible of the chitin deacetylation process.
 </li></ul>
-</p><p>
+</p><p align="justify">
-We are currently patenting our first invention: the design of the genetically modified E. coli able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of BioPhrame Technologies as moral person (once it is legally established).
+We are currently patenting our first invention: the design of the genetically modified <i>E. coli</i> able to deacetylate chitin to produce Chitosan. We started the technology research at the IMPI (Mexican Institute for Intellectual Property), on September 17 (official documents available upon request), and we will start the patent process on January of 2015 in order to apply to government funds. The patent will be registered under the name of Biophrame Technologies as moral person (once it is legally established).
-</p><p>
+</p><p align="justify">
 On the other hand, we will keep our innovative chitosan purification process as a trade secret, but we plan to establish a patent for this invention in other step of our Company development.
 </p>